European Archives - Page 746 of 1169 - European Medical Journal

Who Audits Who Using Resection Margins: The Surgeon, or the Pathologist?

Colorectal cancer (CRC) is one of the most common malignancies in the developed world and with the ‘westernisation’ of diets, other parts of the world…

Practical Management of Anaemia After a Gastrointestinal Bleed

Prof Gralnek opened the symposium with a clinical case: a 52-year old woman presented with dizziness and explained that she had had bloody stools…

Moving Towards a New Era: Algorithms in the Management of Crohn’s Disease

Successful, cost-effective, and efficient management of disease treatment is the driving factor behind many scientific studies, particularly for diseases…

Dysphagia and Bone Marrow Failure: A Rare Neoplastic Mimic

A 54-year-old male with a history of multiple autoimmune arthritides was admitted following a 3-week history of progressive dysphagia with odynophagia…

Switching off Inflammation with Diet: A Review of Exclusive Enteral Nutrition in Children with Crohn’s Disease

The inflammatory bowel diseases (IBD) are a group of conditions characterised by chronic, incurable inflammation in the gastrointestinal (GI) tract…

A Rare Case of an Inflammatory Myofibroblastic Tumour of the Colon as a Probable Result of Tumour Recurrence after Hemicolectomy

Inflammatory myofibroblastic tumour (IMT) is a rare mesenchymal solid tumour commonly documented in children and young adults, but also found…

Possibility of Link Between Dopamine and Childhood Asthma

The NEUROTRANSMITTER dopamine has been shown, in the latest research, to play a key role in development of the sympathetic nerves of the mouse lung in…

Nanoparticle-Immunotherapy as a Novel Treatment for Lung Cancer

INHALABLE nanoparticles have been shown success in animal models to treat lung cancer. The study, carried out by a team supervised by Professor Dawen Zhao…

Building a R&D strategy for the modern age

Low levels of return on investment in R&D is an issue that has been bubbling beneath the surface of pharmaceutical companies for some time and the situation is coming to a head, threatening the industry’s future

Creating the patient-centred trial

Patient recruitment and retention remain the biggest challenges in clinical studies, it is surely time for industry to trial a new approach.